tm
Seeing Is Believing
tm
Seeing Is Believing
ELYM is currently covered by 3 analysts with an average price target of $13.2. This is a potential upside of $3.04 (29.92%) from yesterday's end of day stock price of $10.16.
Eliem Therapeutics's activity chart (see below) currently has 5 price targets and 13 ratings on display. The stock rating distribution of ELYM is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 39.58% with an average time for these price targets to be met of 316.25 days.
Highest price target for ELYM is $4, Lowest price target is $3, average price target is $13.2.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 08-Mar-2023. First documented stock forecast 07-Sep-2021.
Currently out of the existing stock ratings of ELYM, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
6
$-4.16 (-40.94%)
1 years 1 months 27 days ago
2/2 (100%)
$2.36 (64.84%)
485
Buy
4
$-6.16 (-60.63%)
13
1 years 8 months 19 days ago
1/4 (25%)
$1.11 (38.41%)
141
Buy
8
$-2.16 (-21.26%)
1 years 9 months 3 days ago
1/3 (33.33%)
$5.28 (194.12%)
639
Hold
32
2 years 9 days ago
0/1 (0%)
$3.39 (11.85%)
What is ELYM (Eliem Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ELYM (Eliem Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ELYM (Eliem Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?
Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?
Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?
